ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,745.37
      0.00%
      US Tech 100
      19,606.40
      0.14%
      Dow Jones
      42,175.11
      0.00%
      Brent Oil
      70.985
      0.05%
      Bitcoin
      65,627.28
      0.68%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Jazz Pharmaceuticals PLC (JAZZ)

      7. Jazz Pharmaceuticals PLC (JAZZ) News

      JAZZ

      Jazz Pharmaceuticals (JAZZ)

      Jazz Pharmaceuticals PLC
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:JAZZ
      DateTimeSourceHeadlineSymbolCompany
      09/16/20247:30AMPR Newswire (US)Jazz Pharmaceuticals Presents Updated Phase 2 Data for Zanidatamab Demonstrating Increased mPFS in HER2-Positive Metastatic Gastroesophageal Adenocarcinoma at ESMO 2024NASDAQ:JAZZJazz Pharmaceuticals PLC
      09/11/202411:38AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:JAZZJazz Pharmaceuticals PLC
      09/09/20247:58AMPR Newswire (US)Jazz Pharmaceuticals to Present Advancements in Solid Tumor Oncology Research at ESMO 2024NASDAQ:JAZZJazz Pharmaceuticals PLC
      09/06/20244:09PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:JAZZJazz Pharmaceuticals PLC
      09/05/20247:50PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:JAZZJazz Pharmaceuticals PLC
      09/05/20247:30AMPR Newswire (US)Jazz Pharmaceuticals to Present New Data Demonstrating Improved Epilepsy Outcomes with Epidiolex®/Epidyolex® (cannabidiol) at the European Epilepsy Congress 2024NASDAQ:JAZZJazz Pharmaceuticals PLC
      09/04/202412:12AMPR Newswire (US)Jazz Pharmaceuticals Announces Pricing of Private Offering of $850 Million of 3.125% Exchangeable Senior Notes due 2030 and Concurrent Ordinary Share RepurchasesNASDAQ:JAZZJazz Pharmaceuticals PLC
      09/04/202412:00AMPR Newswire (US)Jazz Pharmaceuticals Announces Pricing of Private Offering of $850 Million of 3.125% Exchangeable Senior Notes due 2030 and Concurrent Ordinary Share RepurchasesNASDAQ:JAZZJazz Pharmaceuticals PLC
      09/03/20247:00AMPR Newswire (US)Jazz Pharmaceuticals Announces Private Offering of $850 Million of Exchangeable Senior Notes due 2030 and Concurrent Ordinary Share RepurchasesNASDAQ:JAZZJazz Pharmaceuticals PLC
      08/28/20242:27PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:JAZZJazz Pharmaceuticals PLC
      08/22/20244:05PMPR Newswire (US)Jazz Pharmaceuticals Provides Update on Cannabidiol Oral Solution Phase 3 Trial in Japan in Treatment-Resistant EpilepsiesNASDAQ:JAZZJazz Pharmaceuticals PLC
      08/21/20244:15PMPR Newswire (US)Jazz Pharmaceuticals to Participate in Upcoming September Investor ConferencesNASDAQ:JAZZJazz Pharmaceuticals PLC
      08/21/20244:15PMPR Newswire (US)Jazz Pharmaceuticals to Participate in Upcoming September Investor ConferencesNASDAQ:JAZZJazz Pharmaceuticals PLC
      08/06/20246:45PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:JAZZJazz Pharmaceuticals PLC
      08/06/20246:42PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:JAZZJazz Pharmaceuticals PLC
      08/06/20246:42PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:JAZZJazz Pharmaceuticals PLC
      08/06/20246:40PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:JAZZJazz Pharmaceuticals PLC
      08/06/20246:40PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:JAZZJazz Pharmaceuticals PLC
      08/06/20246:39PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:JAZZJazz Pharmaceuticals PLC
      08/06/20246:39PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:JAZZJazz Pharmaceuticals PLC
      08/06/20244:53PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:JAZZJazz Pharmaceuticals PLC
      08/06/20244:52PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:JAZZJazz Pharmaceuticals PLC
      08/06/20244:50PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:JAZZJazz Pharmaceuticals PLC
      08/06/20244:48PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:JAZZJazz Pharmaceuticals PLC
      08/05/20249:57PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:JAZZJazz Pharmaceuticals PLC
      08/05/20249:55PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:JAZZJazz Pharmaceuticals PLC
      08/05/20249:42PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:JAZZJazz Pharmaceuticals PLC
      08/05/20249:35PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:JAZZJazz Pharmaceuticals PLC
      08/05/20249:29PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:JAZZJazz Pharmaceuticals PLC
      08/05/20249:19PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:JAZZJazz Pharmaceuticals PLC
       Showing the most relevant articles for your search:NASDAQ:JAZZ